Somatic mutations in the p53 gene and prognosis in breast cancer: A meta-analysis

British Journal of Cancer

Volumn 80, Issue 12, 1999, Pages 1968-1973

  Pharaoh, P D P ^a   Day, N E ^b   Caldas, C ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Breast cancer; p53; Prognosis

Indexed keywords

PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; HUMAN; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; GENES, P53; HUMANS; MUTATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 0032814777     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690628     Document Type: Article

References (37)

1. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA and Lonning PE (1996) Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2: 811-814
2. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK and McGuire WL (1993) Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85: 200-206
3. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L and Borresen AL (1993) Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer 68: 540-548
4. Barnes DM, Dublin EA, Fisher CJ, Levison DA and Millis RR (1993) Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum Pathol 24: 469-476
5. Beck T, Weller EE, Weikel W, Brumm C, Wilkens C and Knapstein PG (1995) Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1. Gynaecol Oncol 57: 96-104
6. Bergh J, Norberg T, Sjogren S, Lindgren A and Holmberg L (1995) Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med 1: 1029-1034
7. Berns EM, van Staveren IL, Look MP, Smid M, Klijn JG and Foekens JA (1998) Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer. Br J Cancer 77: 1130-1136
8. Bianchi S, Calzolari A, Vezzosi V, Zampi G, Cardona G, Cataliotti L, Bonardi R and Ciatto S (1997) Lack of prognostic value of p53 protein expression in node-negative breast cancer. Tumori. 83: 669-672
9. Borresen AL, Andersen TT, Eyfjord JE, Cornelis RS, Thorlacius S, Borg A, Johansson U, Theillet C, Scherneck S, Hartman SI, Cornelisse CJ, Hovig E and Devilee P (1995) TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chrom. Cancer 14: 71-75
10. Breslow NE and Day NE (1980) Statistical Methods in Cancer Research, Vol. 1 The Analysis of Case-Control Studies. International Agency for Research on Cancer: Lyon
11. Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD and Parl FF (1994) p35 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Cancer 73: 2147-2156
12. Egger M and Smith GD (1995) Misleading meta-analysis. Br Med J 310: 752-754
13. Elledge RM, Fuqua SA, Clark GM, Pujol P, Allred DC and McGuire WL (1993) Prognostic significance of p53 gene alterations in node-negative breast cancer. Breast Cancer Res Treat 26: 225-235
14. Elledge RM, Clark GM, Fuqua SA, Yu YY and Allred DC (1994) p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer. Cancer Res 54: 3752-3757
15. Falette N, Paperin MP, Treilleux I, Gratadour AC, Peloux N, Mignotte H, Tooke N, Lofman E, Inganas M, Bremond A, Ozturk M and Puisieux A (1998) Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients. Cancer Res 58: 1451-1455
16. Gohring UJ, Scharl A, Heckel C, Ahr A and Crombach G (1995) P53 protein in 204 patients with primary breast carcinoma - immunohistochemical detection and clinical value as a prognostic factor. Arch Gynaecol Obstet 256: 139-146
17. Gretarsdottir S, Tryggvadottir L, Jonasson JG, Sigurdsson H, Olafsdottir K, Agnarsson BA, Ogmundsdottir H and Eyfjord JE (1996) TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material. Br J Cancer 74: 555-561
18. Hartmann A, Blaszyk H, Kovach JS and Sommer SS (1997) The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet 13: 27-33
19. Iacopetta B, Grieu F, Powell B, Soong R, McCaul K and Seshadri R (1998) Analysis of p53 gene mutation by polymerase chain reaction single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer. Clin Cancer Res 4: 1597-1602
20. International Agency for Research into Cancer (1998) The IARC database of somatic p53 mutations in human tumors and cell lines. http://www.iarc.fr/p53/homepage.htm.
21. Isola J, Visakorpi T, Holli K and Kallioniemi OP (1992) Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84: 1109-1114
22. Jansson T, Inganas M, Sjogren S, Norberg T, Lindgren A, Holmberg L and Bergh J (1995) p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings. J Clin Oncol 13: 2745-2751
23. Kovach JS, Hartmann A, Blaszyk H, Cunningham J, Schaid D and Sommer SS (1996) Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci USA 93: 1093-1096
24. Lane DP (1992) Cancer, p53, guardian of the genome. Nature, 358: 15-16
25. Levesque MA, Katsaros D, Yu H, Giai M, Genta F, Roagna R, Ponzone R, Massobrio M, Sismondi P and Diamandis EP (1998) Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients. Int J Cancer 79: 147-152
26. Lipponen P, Ji M, Aaltomaa S, Syrjanen S and Syrjanen K (1993) p53 protein expression in breast cancer as related to histopathological characteristics and prognosis Int J Cancer, 55: 51-56
27. Norberg T, Lennerstrand J, Inganas M and Bergh J (1998) Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors. Int J Cancer 79: 376-383
28. Riou G, Le MG, Travagli JP, Levine AJ and Moll UM (1993) Poor prognosis of p53 gene mutation and nuclear overexpression of p53 protein in inflammatory breast carcinoma. J Natl Cancer Inst 85: 1765-1767
29. Seshadri R, Leong AS, McCaul K, Firgaira FA, Setlur V and Horsfall DJ (1996) Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis. Int J Cancer 69: 135-141
30. Shiao YH, Chen VW, Scheer WD, Wu XC and Correa P (1995) Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res 55: 1485-1490
31. Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G and Veronesi U (1993) p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85: 965-970
32. Soong R, Iacopetta BJ, Harvey JM, Sterrett GF, Dawkins HJ, Hahnel R and Robbins PD (1997) Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer. Int J Cancer 74: 642-647
33. Stenmark-Askmalm M, Stal O, Sullivan S, Ferrand L, Sun XF, Carstensen J and Nordenskjold B (1994) Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer. Eur J Cancer 30A: 175-180
34. Thor AD, Moore DHI II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH and Smith HS (1992) Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845-855
35. Thorlacius S, Thorgilsson B, Bjornsson J, Tryggvadottir L, Borresen AL, Ogmundsdottir HM and Eyfjord JE (1995) TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis. Eur J Cancer 31A: 1856-1861
36. Tsuda H, Sakamaki C, Tsugane S, Fukutomi T and Hirohashi S (1998) A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases. Breast Cancer Res Treat 48: 21-32
37. Valgardsdottir R, Tryggvadottir L, Steinarsdottir M, Olafsdottir K, Jonasdottir S, Jonasson JG, Ogmundsdottir HM and Eyfjord JE (1997) Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis. APMIS 105: 121-130